Ozgur Ozyilkan - Baskent University | 人才画像

基本信息

浏览量：2

职业迁徙

个人简介

Lung cancer and breast cancer

研究兴趣

论文共 243 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

22O Association of Biomarkers with Response to Coformulated Vibostolimab/pembrolizumab (vibo/pembro) in Metastatic Cervical Cancer (CC): Exploratory Analysis from the Phase II KEYVIBE-005 Study

C. Le Tourneau, Carlos A. Rojas,Alexandra Léary, Kan Yonemori,I. Lugowska, Diego Tosi,François Ghiringhelli,Christian Caglevic, E.P. Yanez Ruiz,Ruth Perets,Sun Young Rha,P. Salman, Takako Doi, Y. Zhang, Güray Aktürk, C. Peña, T. Keenan, Y. Chen, Elisha J. Dettman,Özgür Özyılkan

ESMO open (2024): 103522-103522

引用0浏览0引用

855P Safety and Efficacy of Vibostolimab (Anti-Tigit) Coformulated with Pembrolizumab (vibo/pembro) in Previously Untreated Advanced Head and Neck Squamous Cell Carcinoma (HNSCC): Results from the Phase II KEYVIBE-005 Study

C. Toullec, S. Seo, A.G. Robinson, H-H. Chou,P. Salman, F. Ghiringhelli,O. Ozyilkan, C.I. Rojas,M.A.N. Sendur, C. Le Tourneau, C.J. Yen, S. Aksoy,S. Ochsenreither, E.P. Yanez Ruiz, S.Y. Rha,R. Shapira-Frommer, Q. Liu, M. Du Plessis, T. Keenan, C-H. Hsu

Annals of Oncology (2024)

引用0浏览0引用

Heredera Breast Cancer: a Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Giredestrant Plus the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients with Previously Untreated HER2-positive, Estrogen Receptor-Positive Locally Advanced or Metastatic Breast Cancer

Sherko Kuemmel,Catherine Harper-Wynne,Yeon Hee Park,Fábio Franke,Michelino de Laurentiis,Eva Schumacher-Wulf,Daniel Eiger,Sarah Heeson,Andrés Cardona,Özgür Özyilkan,Flavia Morales-Vàsquez,Ciara Metcalfe,Marc Hafner,Eleonora Restuccia,Joyce O’Shaughnessy

BMC CANCERno. 1 (2024)

引用0浏览0WOS引用

Results from Phase 3 KEYLYNK-008: Pembrolizumab (pembro) with and Without Maintenance Olaparib (ola) after First-Line (1L) Pembro Plus Chemotherapy (chemo) for Metastatic Squamous Non-Small-cell Lung Cancer (Sqnsclc)

Maximilian Hochmair,Michael Schenker,Manuel Cobo Dols,Tae Min Kim, Sang-We Kim,Ozgur Ozyilkan, Maria Smagina, Leonova Viktoriya,Terufumi Kato, Alexander Fedenko,Flavia De Angelis,Achim Rittmeyer,Jhanelle E. Gray, Alastair Greystoke, Qinlei Huang, Bin Zhao, Humberto Lara-Guerra, Ernest Nadal

CANCER RESEARCHno. 7 (2024)

引用0浏览0引用

908P Association of Biomarkers with Response to First-Line (1L) Vibostolimab (Anti-Tigit) Coformulated with Pembrolizumab (vibo/pembro) in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC): Results from KEYVIBE-005

S. Seo,B. Calderon, H-H. Chou, C-H. Hsu,P. Salman, F. Ghiringhelli,O. Ozyilkan, C.I. Rojas,M.A.N. Sendur,C. Le Tourneau, C.J. Yen,R. Shapira-Frommer, S.Y. Rha, Y. Zhang, C. Chen, C.E. Pena, T. Keenan, Y. Chen, E. Dettman, A.G. Robinson

Annals of Oncology (2024)

引用0浏览0引用

Frontline Management of Advanced Epithelial Ovarian Cancer: A Comprehensive Statement by the Africa Middle East Cancer Inter-group [AMCI]

Mudieddine Seoud,Amel Ladjeroud,Hassan Jaafar,Mohsen Mokhtar,Ozgur Ozyilkan,Shadi Alkhayyat, Shaheenah Dawood,Zafer Arik,Hamdy A. Azim

CURRENT WOMENS HEALTH REVIEWS（2024）

引用0浏览0引用

Abstract CT034: Results from Phase 3 KEYLYNK-008: Pembrolizumab (pembro) with and Without Maintenance Olaparib (ola) after First-Line (1L) Pembro Plus Chemotherapy (chemo) for Metastatic Squamous Non-Small-cell Lung Cancer (Sqnsclc)

Maximilian Hochmair,Michael Schenker,Manuel Cobo Dols,Tae Min Kim,Sang-We Kim,Ozgur Ozyilkan, Maria Smagina, Leonova Viktoriya,Terufumi Kato, Alexander Fedenko,Flavia De Angelis,Achim Rittmeyer,Jhanelle E. Gray,Alastair Greystoke, Qinlei Huang, Bin Zhao,Humberto Lara-Guerra,Ernest Nadal

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

22O Association of biomarkers with response to coformulated vibostolimab/pembrolizumab (vibo/pembro) in metastatic cervical cancer (CC): Exploratory analysis from the phase II KEYVIBE-005 study

C. Le Tourneau, C.I. Rojas, A. Leary, K. Yonemori,I. Lugowska, D. Tosi, F. Ghiringhelli, C. Caglevic, E.P. Yanez Ruiz,R. Perets, S.Y. Rha,P. Salman, T. Doi, Y. Zhang, G. Akturk, C.E. Pena, T. Keenan, Y. Chen, E. Dettman,O. Ozyilkan

ESMO Open (2024)

引用0浏览0引用

Pembrolizumab with or Without Maintenance Olaparib for Metastatic Squamous Non-Small-Cell Lung Cancer That Responded to First-Line Pembrolizumab Plus Chemotherapy

Maximilian Hochmair,Michael Schenker, Manuel Cobo Dols, Tae Min Kim,Ozgur Ozyilkan, Maria Smagina, Leonova Viktoriya, Terufumi Kato,Alexander Fedenko, Flavia De Angelis,Achim Rittmeyer, Jhanelle E Gray, Alastair Greystoke, Himani Aggarwal, Qinlei Huang, Bin Zhao, Humberto Lara-Guerra,Ernest Nadal

Journal of thoracic oncology official publication of the International Association for the Study of Lung Cancer (2024)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn